Among active 13F managers last quarter, 1 added and none reduced or exited; the largest holder to move was OpenArc Corporate Advisory, LLC (+759%). Over the last 180 days, 3 insiders bought and none sold, a net +$2.7M in open-market trades.
Funds lean in and no leg opposes.
21 tracked 13F filers disclose a position in ONMD as of the latest SEC 13F filings, a combined $14.1M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Exencial Wealth Advisors, LLC | 8.4M | $7.1M | ▲+130% Added · +4.7M sh | Q1 2026 | |
| 2 | Savant Capital, LLC | 7.2M | $5.1M | ▲New +7.2M sh | Q2 2026 | |
| 3 | Vanguard Capital Management LLC | 1.2M | $819K | ▲+3.3% Added · +37K sh | Q2 2026 | |
| 4 | Geode Capital Management, LLC | 334K | $238K | ▼−1.2% Reduced · −4K sh | Q2 2026 | |
| 5 | Vanguard Fiduciary Trust Co | 138K | $98K | ▲+0.8% Added · +1K sh | Q2 2026 | |
| 6 | Citigroup Inc | 135K | $115K | ▲New +135K sh | Q1 2026 | |
| 7 | BlackRock, Inc. | 121K | $86K | ▲+73% Added · +51K sh | Q2 2026 | |
| 8 | State Street Corp | 117K | $83K | —Held | Q2 2026 | |
| 9 | Discovery Capital Management, LLC / CT | 112K | $80K | —Held | Q2 2026 | |
| 10 | Jane Street Group, LLC | 112K | $95K | ▲+3.3% Added · +4K sh | Q1 2026 | |
| 11 | OpenArc Corporate Advisory, LLC | 97K | $69K | ▲+759% Added · +86K sh | Q2 2026 | |
| 12 | Northern Trust Corp | 55K | $47K | —Held | Q1 2026 | |
| 13 | Ashton Thomas Private Wealth, LLC | 27K | $19K | —Held | Q2 2026 | |
| 14 | Focus Partners Wealth | 20K | $17K | ▲+100% Added · +10K sh | Q1 2026 | |
| 15 | Neuberger Berman Group LLC | 20K | $17K | —Held | Q1 2026 | |
| 16 | PNC Financial Services Group, Inc. | 17K | $15K | —Held | Q1 2026 | |
| 17 | UBS Group AG | 16K | $14K | ▼−86% Reduced · −98K sh | Q1 2026 | |
| 18 | Procyon Advisors, LLC | 14K | $10K | —Held | Q2 2026 | |
| 19 | Raymond James Financial Inc | 12K | $10K | ▲New +12K sh | Q1 2026 | |
| 20 | Goldman Sachs Group Inc | 12K | $10K | ▲New +12K sh | Q1 2026 | |
| 21 | SBI Securities Co., Ltd. | 157 | $112 | —Held | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 1 fund added to an existing position in ONMD, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Amazon.com IncAMZN | 5 funds | $3.9B |
| Alphabet Inc-CL AGOOGL | 5 funds | $3.0B |
| JPMorgan Chase & CoJPM | 5 funds | $2.4B |
| Eli Lilly & CoLLY | 5 funds | $1.7B |
| Chevron CorpCVX | 5 funds | $735.6M |
| Sandisk CorpSNDK | 5 funds | $647.4M |
| Advanced Micro DevicesAMD | 5 funds | $601.8M |
| Micron Technology IncMU | 5 funds | $507.9M |
| Lam Research CorpLRCX | 5 funds | $368.9M |
| Goldman Sachs Group IncGS | 5 funds | $342.4M |
| SPDR Gold SharesGLD | 5 funds | $270.3M |
| Capital One Financial CorpCOF | 5 funds | $263.0M |
Ranked by how many of ONMD's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in ONMD.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Sep 10, 2026 | Yu Jeffrey | Chief Medical Officer, Director, 10% Owner | Buy (P) | 143K | $90K |
| Jul 30, 2026 | Kosasa Thomas | Director, 10% Owner | Buy (P) | 1.4M | $1000K |
| Jun 23, 2026 | Green Aaron | Chief Executive Officer, Director | Buy (P) | 37K | $21K |
| Jun 23, 2026 | Yu Jeffrey | Chief Medical Officer, Director, 10% Owner | Buy (P) | 159K | $100K |
| Jun 16, 2026 | Yu Jeffrey | Chief Medical Officer, Director, 10% Owner | Buy (P) | 172K | $100K |
| Jun 15, 2026 | Green Aaron | Chief Executive Officer, Director | Buy (P) | 19K | $10K |
| Jun 12, 2026 | Kosasa Thomas | Director, 10% Owner | Buy (P) | 159K | $100K |
| Jun 12, 2026 | Green Aaron | Chief Executive Officer, Director | Buy (P) | 37K | $21K |
| May 18, 2026 | Kosasa Thomas | Director, 10% Owner | Buy (P) | 269K | $250K |
| Apr 23, 2026 | Kosasa Thomas | Director, 10% Owner | Buy (P) | 281K | $250K |
| Apr 1, 2026 | Yu Jeffrey | Chief Medical Officer, Director, 10% Owner | Buy (P) | 904K | $750K |
| Feb 6, 2026 | Kosasa Thomas | Director, 10% Owner | Buy (P) | 595K | $500K |
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 7 | 2 | – |
Insiders Form 4 open-market | 3 | 0 | +$2.7M |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
| Class | 13F holders | Value held |
|---|---|---|
| ONMDthis pageCommon | 21 funds | $14.1M |
| ONMDWSPAC Combination | 12 funds | $349K |
Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.
Connected entities for ONMD
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ONMD/capital-change-brief"
Use Arkolith's capital_change_brief for ONMD. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ONMD. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.